Amazing news 💙 #gbdoc #T1D breakthrought1d.org.uk/news/mhra-ap...
MHRA approves licencing for teplizumab to be used in the UK | Breakthrough T1D UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed the use of teplizumab in the UK, the first-ever disease-modifying therapy for type 1 diabetes.
breakthrought1d.org.uk